Moderna seeks US authorization of Covid-19 booster shots for all adults
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
January 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JANUARY 30, 2023
Moderna seeks US authorization of Covid-19 booster shots for all adults

Coronavirus chronicle

Reuters
18 November, 2021, 02:25 pm
Last modified: 18 November, 2021, 02:27 pm

Related News

  • Moderna reports positive results for RSV vaccine
  • Moderna refused China request to reveal vaccine technology: Financial Times
  • Moderna sues Pfizer/BioNTech for patent infringement over Covid vaccine
  • Variant-adapted Covid vaccine wins first approval in Britain
  • Special vaccination drive to be extended for 2 more days if target not achieved: DGHS DG  

Moderna seeks US authorization of Covid-19 booster shots for all adults

Moderna's shares rose 5% to $246.16 in afternoon trading on the news

Reuters
18 November, 2021, 02:25 pm
Last modified: 18 November, 2021, 02:27 pm
 Walmart pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine inside a Walmart department store in West Haven, Connecticut, US, February 17, 2021. Photo :Reuters
Walmart pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine inside a Walmart department store in West Haven, Connecticut, US, February 17, 2021. Photo :Reuters

Moderna Inc said on Wednesday it had applied with the U.S. Food and Drug Administration for authorization of its Covid-19 booster vaccine for all adults aged 18 and older.

The FDA has cleared booster shots of Covid-19 vaccines for people who are immunocompromised, those aged 65 and older and for individuals at high risk of severe disease or who are regularly exposed to the virus.

Moderna is seeking authorization for a 50-microgram booster dose, half the strength of its original vaccine given in two shots about four weeks apart.

The filing comes a week after Pfizer Inc applied for a similar clearance for the booster doses of the vaccine it has developed with German partner BioNTech.

A decision from the FDA on Pfizer is expected this week ahead of a US Centers for Disease Control and Prevention (CDC) advisory panel meeting on Friday to discuss expanding the eligibility for booster doses of the vaccine.

Moderna's shares rose 5% to $246.16 in afternoon trading on the news.

Experts believe booster doses are vital for reducing Covid-19 to an endemic level and U.S. President Joe Biden's administration in August announced plans to roll out booster doses for all adults in September.

Last month, the European Union's drug regulator approved Moderna's booster vaccine for all age groups over 18, at least six months after the second dose. The company has also applied for booster approval in Japan.

However, regulators in several countries, including France, Canada, Finland and Sweden, have taken a more defensive stance on Moderna's vaccine over heart-related safety concerns affecting younger people.

Top News / World+Biz

Moderna / Booster Jabs

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Bloomberg
    Adani rout hits $71 billion as fight with Hindenburg intensifies
  • Prime Minister Sheikh Hasina. Sketch: TBS
    Continued democracy helps rapid development: PM Hasina
  • Representational image. Photo: Mumit M/ TBS
    Stocks slide down for second consecutive day

MOST VIEWED

  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs
  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  •  A medical worker checks the IV drip treatment of a patient lying on a bed in the emergency department of a hospital, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China, January 5, 2023. REUTERS/Staff
    China says Covid deaths down by nearly 80 percent
  • Sean Bagley, 14, receives the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    Updated Covid vaccines prevented illness from latest variants -CDC

Related News

  • Moderna reports positive results for RSV vaccine
  • Moderna refused China request to reveal vaccine technology: Financial Times
  • Moderna sues Pfizer/BioNTech for patent infringement over Covid vaccine
  • Variant-adapted Covid vaccine wins first approval in Britain
  • Special vaccination drive to be extended for 2 more days if target not achieved: DGHS DG  

Features

Photo: Courtesy

The Hawkers: Where minimalism meets motifs

6h | Brands
TBS illustration

Where do Shariah-compliant mutual funds stand in Bangladesh

4h | Panorama
Sketch: TBS

A subsidy war without winners

4h | Panorama
Photo: Collected

Oppo Reno 8T first look revealed!

5h | Brands

More Videos from TBS

Youths at the invitation of TBS

Youths at the invitation of TBS

9m | TBS Graduates
Predicting next three years is tough- Kutubuddin Ahmed

Predicting next three years is tough- Kutubuddin Ahmed

1h | TBS Round Table
Pakistan plunges into economic mess

Pakistan plunges into economic mess

3h | TBS World
Shahrukh's 'Pathaan' has been making records ever since its release

Shahrukh's 'Pathaan' has been making records ever since its release

3h | TBS Entertainment

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

4
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

5
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]